<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2024-464
Date of Submission: 2024-09-13

This report was submitted by a Physician from Thompson, Summers and Monroe Medical Center concerning patient ANON-PX-2411. The subject is a 54-year-old other with a significant medical history including type 2 diabetes, hypertension. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Omeprazole (Proton-pump inhibitor) administered via the Oral route at a dosage of 397mg, initiated on 2024-08-31 for Gastroesophageal reflux disease and discontinued on 2024-09-08; Atorvastatin (Statin) administered via the Topical route at a dosage of 215mg, initiated on 2024-08-31 for Hypercholesterolemia and discontinued on 2024-09-08.

On approximately 2024-09-05, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Dizziness, Vomiting. The Dizziness was classified as Moderate in severity. This necessitated clinical intervention. The current patient status regarding this symptom is 'Unknown'. The Vomiting was classified as Life-threatening in severity. This necessitated clinical intervention. The documented action was: Prescribed trial and advised car. The current patient status regarding this symptom is 'Unknown'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. A Naranjo score of 3 was calculated, The assessment concluded the relationship was 'Possible'. Dechallenge/Rechallenge status was noted as: 'Rechallenge not performed'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Professional participant nothing than outside from after. Behind there air look. Seek listen other yes everything several.</data>
report_id: ADR-2024-464
report_date: '2024-09-13'
patient_details:
  patient_id: ANON-PX-2411
  gender: Other
  relevant_history:
  - type 2 diabetes
  - hypertension
  age_at_reaction: 54
suspected_drugs:
- drug_name: Omeprazole
  dosage: 397mg
  route_of_administration: Oral
  start_date: '2024-08-31'
  indication_for_use: Gastroesophageal reflux disease
  drug_class: Proton-pump inhibitor
  end_date: '2024-09-08'
- drug_name: Atorvastatin
  dosage: 215mg
  route_of_administration: Topical
  start_date: '2024-08-31'
  indication_for_use: Hypercholesterolemia
  drug_class: Statin
  end_date: '2024-09-08'
adverse_reactions:
- symptom_name: Dizziness
  onset_date: '2024-09-05'
  severity: Moderate
  outcome: Unknown
  intervention_required: true
- symptom_name: Vomiting
  onset_date: '2024-09-05'
  severity: Life-threatening
  outcome: Unknown
  intervention_required: true
  intervention_details: Prescribed trial and advised car.
causality_assessment:
  assessment_conclusion: Possible
  dechallenge_rechallenge: Rechallenge not performed
  naranjo_score: 3
reporting_facility: Thompson, Summers and Monroe Medical Center
reporter_type: Physician
notes: Professional participant nothing than outside from after. Behind there air
  look. Seek listen other yes everything several.
